Beta Bionics (BBNX) Gross Profit (2024 - 2026)

Beta Bionics' Gross Profit history runs 3 years deep, the most recent figure standing at $16.4 million for Q1 2026.

• In Q1 2026, Gross Profit rose 83.22% year-over-year to $16.4 million; the TTM figure through Mar 2026 stood at $63.0 million (up 67.3% YoY), while the FY2025 annual figure was $55.5 million, up 54.75% from the prior year.
• Gross Profit came in at $16.4 million for Q1 2026 at Beta Bionics, down from $18.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $18.9 million in Q4 2025 to a low of $7.2 million in Q1 2024.
• A 3-year average of $12.0 million and a median of $11.7 million in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit gained 24.58% in 2025 and jumped 83.22% in 2026, its largest moves.
• Beta Bionics' Gross Profit stood at $11.7 million in 2024, then soared by 62.07% to $18.9 million in 2025, then slipped by 13.23% to $16.4 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $16.4 million, $18.9 million, and $15.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison